產(chǎn)品名稱 GDC 0449 - Vismodegib | HhAntag 691
產(chǎn)品貨號(hào) Axon 1500 CAS [879085-55-9] MF C19H14Cl2N2O3SMW 421.30 Purity: 99% Soluble in DMSO Description The first-in-class inhibitor of Hedgehog (Hh) signaling pathway; more specifically, an orally bioavailable and potent inhibitor of smoothened homologue (SMO); an investigational anti-cancer drug for Medulloblastoma, advanced basal cell skin cancer etc References Certificates Categories Extra info CM Rudin et al. Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449. N. Engl. J. Med. 2009, 361, 1173-8.? ? SJ Scales and FJ de Sauvage. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci. 2009, 30(6), 303-312.? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology CNS Stem Cell Smoothened (SMO) Hedgehog F Hedgehog (Hh) pathway inhibitor Chemical name 2-Chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide Parent CAS No. [879085-55-9] Order Size Unit Price Stock 5 mg €80.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

GDC 0449 - Vismodegib | HhAntag 691

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1500

CAS [879085-55-9]

MF C19H14Cl2N2O3S
MW 421.30

  • Purity: 99%
  • Soluble in DMSO

GDC 0449

Description

The first-in-class inhibitor of Hedgehog (Hh) signaling pathway; more specifically, an orally bioavailable and potent inhibitor of smoothened homologue (SMO); an investigational anti-cancer drug for Medulloblastoma, advanced basal cell skin cancer etc
產(chǎn)品資料